nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—PTGS2—atherosclerosis	0.601	1	CbGaD
Risedronate—PTGS2—leg—atherosclerosis	0.00522	0.152	CbGeAlD
Risedronate—PTGS2—hindlimb—atherosclerosis	0.00466	0.135	CbGeAlD
Risedronate—PTGS2—appendage—atherosclerosis	0.004	0.116	CbGeAlD
Risedronate—FDPS—connective tissue—atherosclerosis	0.00298	0.0864	CbGeAlD
Risedronate—Histamine Phosphate—HRH1—atherosclerosis	0.00289	1	CrCbGaD
Risedronate—PTGS2—artery—atherosclerosis	0.00286	0.0829	CbGeAlD
Risedronate—FDPS—cardiovascular system—atherosclerosis	0.00259	0.0752	CbGeAlD
Risedronate—PTGS2—endothelium—atherosclerosis	0.00242	0.0701	CbGeAlD
Risedronate—FDPS—adipose tissue—atherosclerosis	0.00229	0.0663	CbGeAlD
Risedronate—PTGS2—blood vessel—atherosclerosis	0.00223	0.0646	CbGeAlD
Risedronate—FDPS—liver—atherosclerosis	0.0016	0.0465	CbGeAlD
Risedronate—PTGS2—connective tissue—atherosclerosis	0.00114	0.0331	CbGeAlD
Risedronate—PTGS2—cardiovascular system—atherosclerosis	0.000994	0.0288	CbGeAlD
Risedronate—Liver function test abnormal—Niacin—atherosclerosis	0.00095	0.00403	CcSEcCtD
Risedronate—Upper respiratory tract infection—Ezetimibe—atherosclerosis	0.000944	0.00401	CcSEcCtD
Risedronate—Liver function test abnormal—Pravastatin—atherosclerosis	0.000936	0.00397	CcSEcCtD
Risedronate—Bronchitis—Simvastatin—atherosclerosis	0.000932	0.00396	CcSEcCtD
Risedronate—Abdominal discomfort—Simvastatin—atherosclerosis	0.000929	0.00394	CcSEcCtD
Risedronate—Muscular weakness—Niacin—atherosclerosis	0.000908	0.00385	CcSEcCtD
Risedronate—Nasopharyngitis—Pravastatin—atherosclerosis	0.000906	0.00385	CcSEcCtD
Risedronate—Infestation NOS—Ezetimibe—atherosclerosis	0.000906	0.00385	CcSEcCtD
Risedronate—Infestation—Ezetimibe—atherosclerosis	0.000906	0.00385	CcSEcCtD
Risedronate—Upper respiratory tract infection—Simvastatin—atherosclerosis	0.000901	0.00382	CcSEcCtD
Risedronate—Urinary tract infection—Lovastatin—atherosclerosis	0.000898	0.00381	CcSEcCtD
Risedronate—Abdominal distension—Niacin—atherosclerosis	0.000896	0.0038	CcSEcCtD
Risedronate—Muscular weakness—Pravastatin—atherosclerosis	0.000894	0.00379	CcSEcCtD
Risedronate—Influenza—Niacin—atherosclerosis	0.00089	0.00378	CcSEcCtD
Risedronate—Abdominal distension—Pravastatin—atherosclerosis	0.000882	0.00374	CcSEcCtD
Risedronate—PTGS2—adipose tissue—atherosclerosis	0.000876	0.0254	CbGeAlD
Risedronate—Influenza—Pravastatin—atherosclerosis	0.000876	0.00372	CcSEcCtD
Risedronate—Arrhythmia—Rosuvastatin—atherosclerosis	0.000874	0.00371	CcSEcCtD
Risedronate—Angina pectoris—Niacin—atherosclerosis	0.000867	0.00368	CcSEcCtD
Risedronate—Sinusitis—Lovastatin—atherosclerosis	0.000867	0.00368	CcSEcCtD
Risedronate—Depression—Simvastatin—atherosclerosis	0.000862	0.00366	CcSEcCtD
Risedronate—Mental disorder—Rosuvastatin—atherosclerosis	0.000857	0.00364	CcSEcCtD
Risedronate—Hepatobiliary disease—Ezetimibe—atherosclerosis	0.000857	0.00364	CcSEcCtD
Risedronate—Bronchitis—Niacin—atherosclerosis	0.000856	0.00363	CcSEcCtD
Risedronate—Angina pectoris—Pravastatin—atherosclerosis	0.000853	0.00362	CcSEcCtD
Risedronate—Sinusitis—Ezetimibe—atherosclerosis	0.00085	0.00361	CcSEcCtD
Risedronate—Flatulence—Rosuvastatin—atherosclerosis	0.000839	0.00356	CcSEcCtD
Risedronate—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.000814	0.00346	CcSEcCtD
Risedronate—Sinusitis—Simvastatin—atherosclerosis	0.000811	0.00344	CcSEcCtD
Risedronate—Pharyngitis—Ezetimibe—atherosclerosis	0.000807	0.00343	CcSEcCtD
Risedronate—Oedema peripheral—Ezetimibe—atherosclerosis	0.000801	0.0034	CcSEcCtD
Risedronate—Connective tissue disorder—Ezetimibe—atherosclerosis	0.000799	0.00339	CcSEcCtD
Risedronate—Depression—Pravastatin—atherosclerosis	0.000779	0.00331	CcSEcCtD
Risedronate—Angioedema—Rosuvastatin—atherosclerosis	0.000778	0.0033	CcSEcCtD
Risedronate—Urinary tract infection—Pravastatin—atherosclerosis	0.000759	0.00322	CcSEcCtD
Risedronate—Cough—Rosuvastatin—atherosclerosis	0.000743	0.00315	CcSEcCtD
Risedronate—Angiopathy—Ezetimibe—atherosclerosis	0.000738	0.00313	CcSEcCtD
Risedronate—Immune system disorder—Ezetimibe—atherosclerosis	0.000735	0.00312	CcSEcCtD
Risedronate—Mediastinal disorder—Ezetimibe—atherosclerosis	0.000733	0.00311	CcSEcCtD
Risedronate—Sinusitis—Pravastatin—atherosclerosis	0.000733	0.00311	CcSEcCtD
Risedronate—Arthralgia—Rosuvastatin—atherosclerosis	0.000725	0.00308	CcSEcCtD
Risedronate—Myalgia—Rosuvastatin—atherosclerosis	0.000725	0.00308	CcSEcCtD
Risedronate—Haemoglobin—Niacin—atherosclerosis	0.000716	0.00304	CcSEcCtD
Risedronate—Rhinitis—Niacin—atherosclerosis	0.000714	0.00303	CcSEcCtD
Risedronate—Mental disorder—Ezetimibe—atherosclerosis	0.000713	0.00302	CcSEcCtD
Risedronate—Haemorrhage—Niacin—atherosclerosis	0.000712	0.00302	CcSEcCtD
Risedronate—Flatulence—Lovastatin—atherosclerosis	0.000711	0.00302	CcSEcCtD
Risedronate—Malnutrition—Ezetimibe—atherosclerosis	0.000708	0.00301	CcSEcCtD
Risedronate—Rhinitis—Pravastatin—atherosclerosis	0.000703	0.00298	CcSEcCtD
Risedronate—Oedema peripheral—Niacin—atherosclerosis	0.000702	0.00298	CcSEcCtD
Risedronate—Back pain—Lovastatin—atherosclerosis	0.000698	0.00296	CcSEcCtD
Risedronate—Flatulence—Ezetimibe—atherosclerosis	0.000698	0.00296	CcSEcCtD
Risedronate—Pharyngitis—Pravastatin—atherosclerosis	0.000696	0.00295	CcSEcCtD
Risedronate—Muscle spasms—Lovastatin—atherosclerosis	0.000694	0.00295	CcSEcCtD
Risedronate—Infection—Rosuvastatin—atherosclerosis	0.000691	0.00293	CcSEcCtD
Risedronate—Back pain—Ezetimibe—atherosclerosis	0.000685	0.00291	CcSEcCtD
Risedronate—Nervous system disorder—Rosuvastatin—atherosclerosis	0.000682	0.00289	CcSEcCtD
Risedronate—Muscle spasms—Ezetimibe—atherosclerosis	0.000681	0.00289	CcSEcCtD
Risedronate—Mental disorder—Simvastatin—atherosclerosis	0.00068	0.00288	CcSEcCtD
Risedronate—Eye disorder—Niacin—atherosclerosis	0.000666	0.00283	CcSEcCtD
Risedronate—Flatulence—Simvastatin—atherosclerosis	0.000665	0.00282	CcSEcCtD
Risedronate—Tinnitus—Niacin—atherosclerosis	0.000664	0.00282	CcSEcCtD
Risedronate—Angioedema—Lovastatin—atherosclerosis	0.00066	0.0028	CcSEcCtD
Risedronate—Anaemia—Ezetimibe—atherosclerosis	0.000654	0.00278	CcSEcCtD
Risedronate—Tinnitus—Pravastatin—atherosclerosis	0.000654	0.00278	CcSEcCtD
Risedronate—Cardiac disorder—Pravastatin—atherosclerosis	0.000651	0.00276	CcSEcCtD
Risedronate—Muscle spasms—Simvastatin—atherosclerosis	0.000649	0.00276	CcSEcCtD
Risedronate—Vertigo—Lovastatin—atherosclerosis	0.000649	0.00275	CcSEcCtD
Risedronate—Angioedema—Ezetimibe—atherosclerosis	0.000647	0.00275	CcSEcCtD
Risedronate—Angiopathy—Niacin—atherosclerosis	0.000646	0.00274	CcSEcCtD
Risedronate—Arrhythmia—Niacin—atherosclerosis	0.000636	0.0027	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000633	0.00269	CcSEcCtD
Risedronate—Insomnia—Rosuvastatin—atherosclerosis	0.000629	0.00267	CcSEcCtD
Risedronate—Arrhythmia—Pravastatin—atherosclerosis	0.000626	0.00266	CcSEcCtD
Risedronate—Paraesthesia—Rosuvastatin—atherosclerosis	0.000624	0.00265	CcSEcCtD
Risedronate—Anaemia—Simvastatin—atherosclerosis	0.000624	0.00265	CcSEcCtD
Risedronate—Malnutrition—Niacin—atherosclerosis	0.00062	0.00263	CcSEcCtD
Risedronate—Cough—Ezetimibe—atherosclerosis	0.000618	0.00262	CcSEcCtD
Risedronate—Angioedema—Simvastatin—atherosclerosis	0.000617	0.00262	CcSEcCtD
Risedronate—Chest pain—Lovastatin—atherosclerosis	0.000615	0.00261	CcSEcCtD
Risedronate—Myalgia—Lovastatin—atherosclerosis	0.000615	0.00261	CcSEcCtD
Risedronate—Arthralgia—Lovastatin—atherosclerosis	0.000615	0.00261	CcSEcCtD
Risedronate—PTGS2—liver—atherosclerosis	0.000614	0.0178	CbGeAlD
Risedronate—Anxiety—Lovastatin—atherosclerosis	0.000612	0.0026	CcSEcCtD
Risedronate—Dyspepsia—Rosuvastatin—atherosclerosis	0.000612	0.0026	CcSEcCtD
Risedronate—Hypertension—Ezetimibe—atherosclerosis	0.000611	0.00259	CcSEcCtD
Risedronate—Flatulence—Niacin—atherosclerosis	0.000611	0.00259	CcSEcCtD
Risedronate—Vertigo—Simvastatin—atherosclerosis	0.000607	0.00257	CcSEcCtD
Risedronate—Arthralgia—Ezetimibe—atherosclerosis	0.000603	0.00256	CcSEcCtD
Risedronate—Chest pain—Ezetimibe—atherosclerosis	0.000603	0.00256	CcSEcCtD
Risedronate—Myalgia—Ezetimibe—atherosclerosis	0.000603	0.00256	CcSEcCtD
Risedronate—Flatulence—Pravastatin—atherosclerosis	0.000602	0.00255	CcSEcCtD
Risedronate—Dry mouth—Lovastatin—atherosclerosis	0.000601	0.00255	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Ezetimibe—atherosclerosis	0.000599	0.00254	CcSEcCtD
Risedronate—Muscle spasms—Niacin—atherosclerosis	0.000596	0.00253	CcSEcCtD
Risedronate—Constipation—Rosuvastatin—atherosclerosis	0.000594	0.00252	CcSEcCtD
Risedronate—Pain—Rosuvastatin—atherosclerosis	0.000594	0.00252	CcSEcCtD
Risedronate—Dry mouth—Ezetimibe—atherosclerosis	0.00059	0.0025	CcSEcCtD
Risedronate—Muscle spasms—Pravastatin—atherosclerosis	0.000587	0.00249	CcSEcCtD
Risedronate—Infection—Lovastatin—atherosclerosis	0.000585	0.00248	CcSEcCtD
Risedronate—Chest pain—Simvastatin—atherosclerosis	0.000575	0.00244	CcSEcCtD
Risedronate—Arthralgia—Simvastatin—atherosclerosis	0.000575	0.00244	CcSEcCtD
Risedronate—Myalgia—Simvastatin—atherosclerosis	0.000575	0.00244	CcSEcCtD
Risedronate—Infection—Ezetimibe—atherosclerosis	0.000574	0.00244	CcSEcCtD
Risedronate—Anxiety—Simvastatin—atherosclerosis	0.000573	0.00243	CcSEcCtD
Risedronate—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000568	0.00241	CcSEcCtD
Risedronate—Nervous system disorder—Ezetimibe—atherosclerosis	0.000567	0.00241	CcSEcCtD
Risedronate—Angioedema—Niacin—atherosclerosis	0.000567	0.0024	CcSEcCtD
Risedronate—Anaemia—Pravastatin—atherosclerosis	0.000564	0.00239	CcSEcCtD
Risedronate—Skin disorder—Ezetimibe—atherosclerosis	0.000561	0.00238	CcSEcCtD
Risedronate—Angioedema—Pravastatin—atherosclerosis	0.000558	0.00237	CcSEcCtD
Risedronate—Vertigo—Niacin—atherosclerosis	0.000557	0.00236	CcSEcCtD
Risedronate—Syncope—Niacin—atherosclerosis	0.000556	0.00236	CcSEcCtD
Risedronate—Urticaria—Rosuvastatin—atherosclerosis	0.000552	0.00234	CcSEcCtD
Risedronate—Abdominal pain—Rosuvastatin—atherosclerosis	0.00055	0.00233	CcSEcCtD
Risedronate—Vertigo—Pravastatin—atherosclerosis	0.000548	0.00233	CcSEcCtD
Risedronate—Infection—Simvastatin—atherosclerosis	0.000547	0.00232	CcSEcCtD
Risedronate—Loss of consciousness—Niacin—atherosclerosis	0.000545	0.00231	CcSEcCtD
Risedronate—Cough—Niacin—atherosclerosis	0.000541	0.0023	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000537	0.00228	CcSEcCtD
Risedronate—Insomnia—Lovastatin—atherosclerosis	0.000533	0.00226	CcSEcCtD
Risedronate—Cough—Pravastatin—atherosclerosis	0.000533	0.00226	CcSEcCtD
Risedronate—Paraesthesia—Lovastatin—atherosclerosis	0.000529	0.00225	CcSEcCtD
Risedronate—Myalgia—Niacin—atherosclerosis	0.000528	0.00224	CcSEcCtD
Risedronate—Arthralgia—Niacin—atherosclerosis	0.000528	0.00224	CcSEcCtD
Risedronate—Hypertension—Pravastatin—atherosclerosis	0.000527	0.00224	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000526	0.00223	CcSEcCtD
Risedronate—Dyspnoea—Lovastatin—atherosclerosis	0.000525	0.00223	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Niacin—atherosclerosis	0.000524	0.00222	CcSEcCtD
Risedronate—Insomnia—Ezetimibe—atherosclerosis	0.000523	0.00222	CcSEcCtD
Risedronate—Arthralgia—Pravastatin—atherosclerosis	0.00052	0.00221	CcSEcCtD
Risedronate—Chest pain—Pravastatin—atherosclerosis	0.00052	0.00221	CcSEcCtD
Risedronate—Myalgia—Pravastatin—atherosclerosis	0.00052	0.00221	CcSEcCtD
Risedronate—Paraesthesia—Ezetimibe—atherosclerosis	0.000519	0.0022	CcSEcCtD
Risedronate—Dyspepsia—Lovastatin—atherosclerosis	0.000519	0.0022	CcSEcCtD
Risedronate—Anxiety—Pravastatin—atherosclerosis	0.000518	0.0022	CcSEcCtD
Risedronate—Dry mouth—Niacin—atherosclerosis	0.000516	0.00219	CcSEcCtD
Risedronate—Dyspnoea—Ezetimibe—atherosclerosis	0.000515	0.00219	CcSEcCtD
Risedronate—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000512	0.00217	CcSEcCtD
Risedronate—Dyspepsia—Ezetimibe—atherosclerosis	0.000509	0.00216	CcSEcCtD
Risedronate—Fatigue—Lovastatin—atherosclerosis	0.000508	0.00216	CcSEcCtD
Risedronate—Pain—Lovastatin—atherosclerosis	0.000504	0.00214	CcSEcCtD
Risedronate—Constipation—Lovastatin—atherosclerosis	0.000504	0.00214	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000502	0.00213	CcSEcCtD
Risedronate—Gastrointestinal disorder—Ezetimibe—atherosclerosis	0.000499	0.00212	CcSEcCtD
Risedronate—Asthenia—Rosuvastatin—atherosclerosis	0.000499	0.00212	CcSEcCtD
Risedronate—Insomnia—Simvastatin—atherosclerosis	0.000498	0.00212	CcSEcCtD
Risedronate—Fatigue—Ezetimibe—atherosclerosis	0.000498	0.00211	CcSEcCtD
Risedronate—Shock—Niacin—atherosclerosis	0.000498	0.00211	CcSEcCtD
Risedronate—Infection—Pravastatin—atherosclerosis	0.000495	0.0021	CcSEcCtD
Risedronate—Paraesthesia—Simvastatin—atherosclerosis	0.000495	0.0021	CcSEcCtD
Risedronate—Pain—Ezetimibe—atherosclerosis	0.000494	0.0021	CcSEcCtD
Risedronate—Constipation—Ezetimibe—atherosclerosis	0.000494	0.0021	CcSEcCtD
Risedronate—Pruritus—Rosuvastatin—atherosclerosis	0.000492	0.00209	CcSEcCtD
Risedronate—Skin disorder—Niacin—atherosclerosis	0.000491	0.00209	CcSEcCtD
Risedronate—Dyspnoea—Simvastatin—atherosclerosis	0.000491	0.00209	CcSEcCtD
Risedronate—Dyspepsia—Simvastatin—atherosclerosis	0.000485	0.00206	CcSEcCtD
Risedronate—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000482	0.00204	CcSEcCtD
Risedronate—Gastrointestinal disorder—Simvastatin—atherosclerosis	0.000476	0.00202	CcSEcCtD
Risedronate—Diarrhoea—Rosuvastatin—atherosclerosis	0.000476	0.00202	CcSEcCtD
Risedronate—Fatigue—Simvastatin—atherosclerosis	0.000475	0.00202	CcSEcCtD
Risedronate—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000473	0.00201	CcSEcCtD
Risedronate—Pain—Simvastatin—atherosclerosis	0.000471	0.002	CcSEcCtD
Risedronate—Constipation—Simvastatin—atherosclerosis	0.000471	0.002	CcSEcCtD
Risedronate—Urticaria—Lovastatin—atherosclerosis	0.000468	0.00199	CcSEcCtD
Risedronate—Abdominal pain—Lovastatin—atherosclerosis	0.000466	0.00198	CcSEcCtD
Risedronate—Body temperature increased—Lovastatin—atherosclerosis	0.000466	0.00198	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000461	0.00196	CcSEcCtD
Risedronate—Dizziness—Rosuvastatin—atherosclerosis	0.00046	0.00195	CcSEcCtD
Risedronate—Urticaria—Ezetimibe—atherosclerosis	0.000459	0.00195	CcSEcCtD
Risedronate—Insomnia—Niacin—atherosclerosis	0.000458	0.00194	CcSEcCtD
Risedronate—Abdominal pain—Ezetimibe—atherosclerosis	0.000457	0.00194	CcSEcCtD
Risedronate—Body temperature increased—Ezetimibe—atherosclerosis	0.000457	0.00194	CcSEcCtD
Risedronate—Paraesthesia—Niacin—atherosclerosis	0.000454	0.00193	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000454	0.00193	CcSEcCtD
Risedronate—Dyspnoea—Niacin—atherosclerosis	0.000451	0.00191	CcSEcCtD
Risedronate—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000451	0.00191	CcSEcCtD
Risedronate—Insomnia—Pravastatin—atherosclerosis	0.000451	0.00191	CcSEcCtD
Risedronate—Paraesthesia—Pravastatin—atherosclerosis	0.000447	0.0019	CcSEcCtD
Risedronate—Dyspepsia—Niacin—atherosclerosis	0.000445	0.00189	CcSEcCtD
Risedronate—Dyspnoea—Pravastatin—atherosclerosis	0.000444	0.00189	CcSEcCtD
Risedronate—PTGS2—Signaling mediated by p38-alpha and p38-beta—NOS2—atherosclerosis	0.000439	0.00348	CbGpPWpGaD
Risedronate—Dyspepsia—Pravastatin—atherosclerosis	0.000439	0.00186	CcSEcCtD
Risedronate—Rash—Rosuvastatin—atherosclerosis	0.000438	0.00186	CcSEcCtD
Risedronate—PTGS2—Selenium Micronutrient Network—MPO—atherosclerosis	0.000438	0.00347	CbGpPWpGaD
Risedronate—Dermatitis—Rosuvastatin—atherosclerosis	0.000438	0.00186	CcSEcCtD
Risedronate—Urticaria—Simvastatin—atherosclerosis	0.000438	0.00186	CcSEcCtD
Risedronate—Gastrointestinal disorder—Niacin—atherosclerosis	0.000437	0.00185	CcSEcCtD
Risedronate—Body temperature increased—Simvastatin—atherosclerosis	0.000436	0.00185	CcSEcCtD
Risedronate—Abdominal pain—Simvastatin—atherosclerosis	0.000436	0.00185	CcSEcCtD
Risedronate—Headache—Rosuvastatin—atherosclerosis	0.000436	0.00185	CcSEcCtD
Risedronate—PTGS2—Selenium Micronutrient Network—LDLR—atherosclerosis	0.000435	0.00345	CbGpPWpGaD
Risedronate—Hypersensitivity—Lovastatin—atherosclerosis	0.000434	0.00184	CcSEcCtD
Risedronate—Pain—Niacin—atherosclerosis	0.000433	0.00184	CcSEcCtD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—atherosclerosis	0.000431	0.00341	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—CD36—atherosclerosis	0.00043	0.0034	CbGpPWpGaD
Risedronate—Fatigue—Pravastatin—atherosclerosis	0.00043	0.00182	CcSEcCtD
Risedronate—Constipation—Pravastatin—atherosclerosis	0.000426	0.00181	CcSEcCtD
Risedronate—Pain—Pravastatin—atherosclerosis	0.000426	0.00181	CcSEcCtD
Risedronate—Hypersensitivity—Ezetimibe—atherosclerosis	0.000426	0.00181	CcSEcCtD
Risedronate—Asthenia—Lovastatin—atherosclerosis	0.000423	0.00179	CcSEcCtD
Risedronate—PTGS2—Selenium Micronutrient Network—F7—atherosclerosis	0.000421	0.00333	CbGpPWpGaD
Risedronate—Pruritus—Lovastatin—atherosclerosis	0.000417	0.00177	CcSEcCtD
Risedronate—PTGS2—S1P1 pathway—VEGFA—atherosclerosis	0.000415	0.00328	CbGpPWpGaD
Risedronate—Asthenia—Ezetimibe—atherosclerosis	0.000415	0.00176	CcSEcCtD
Risedronate—Gastrointestinal pain—Niacin—atherosclerosis	0.000414	0.00176	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	0.000414	0.00327	CbGpPWpGaD
Risedronate—Nausea—Rosuvastatin—atherosclerosis	0.000413	0.00175	CcSEcCtD
Risedronate—PTGS2—Arachidonic acid metabolism—GPX1—atherosclerosis	0.000413	0.00327	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	0.000411	0.00325	CbGpPWpGaD
Risedronate—Pruritus—Ezetimibe—atherosclerosis	0.000409	0.00174	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	0.000408	0.00323	CbGpPWpGaD
Risedronate—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000407	0.00173	CcSEcCtD
Risedronate—PTGS2—Selenium Micronutrient Network—SCARB1—atherosclerosis	0.000407	0.00322	CbGpPWpGaD
Risedronate—Hypersensitivity—Simvastatin—atherosclerosis	0.000406	0.00172	CcSEcCtD
Risedronate—Diarrhoea—Lovastatin—atherosclerosis	0.000403	0.00171	CcSEcCtD
Risedronate—Urticaria—Niacin—atherosclerosis	0.000402	0.00171	CcSEcCtD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—atherosclerosis	0.000401	0.00317	CbGpPWpGaD
Risedronate—Abdominal pain—Niacin—atherosclerosis	0.0004	0.0017	CcSEcCtD
Risedronate—Body temperature increased—Niacin—atherosclerosis	0.0004	0.0017	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	0.000399	0.00316	CbGpPWpGaD
Risedronate—Urticaria—Pravastatin—atherosclerosis	0.000396	0.00168	CcSEcCtD
Risedronate—Asthenia—Simvastatin—atherosclerosis	0.000395	0.00168	CcSEcCtD
Risedronate—Diarrhoea—Ezetimibe—atherosclerosis	0.000395	0.00168	CcSEcCtD
Risedronate—FDPS—SREBP signalling—AKT1—atherosclerosis	0.000394	0.00312	CbGpPWpGaD
Risedronate—Abdominal pain—Pravastatin—atherosclerosis	0.000394	0.00167	CcSEcCtD
Risedronate—Body temperature increased—Pravastatin—atherosclerosis	0.000394	0.00167	CcSEcCtD
Risedronate—PTGS2—S1P1 pathway—MAPK3—atherosclerosis	0.000392	0.00311	CbGpPWpGaD
Risedronate—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—atherosclerosis	0.000392	0.0031	CbGpPWpGaD
Risedronate—Pruritus—Simvastatin—atherosclerosis	0.00039	0.00165	CcSEcCtD
Risedronate—Dizziness—Lovastatin—atherosclerosis	0.00039	0.00165	CcSEcCtD
Risedronate—FDPS—Metabolism—ABCG8—atherosclerosis	0.000387	0.00306	CbGpPWpGaD
Risedronate—FDPS—Metabolism—LTA4H—atherosclerosis	0.000387	0.00306	CbGpPWpGaD
Risedronate—Dizziness—Ezetimibe—atherosclerosis	0.000382	0.00162	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	0.000382	0.00302	CbGpPWpGaD
Risedronate—Diarrhoea—Simvastatin—atherosclerosis	0.000377	0.0016	CcSEcCtD
Risedronate—PTGS2—Selenium Micronutrient Network—PLAT—atherosclerosis	0.000375	0.00297	CbGpPWpGaD
Risedronate—Vomiting—Lovastatin—atherosclerosis	0.000375	0.00159	CcSEcCtD
Risedronate—Hypersensitivity—Niacin—atherosclerosis	0.000373	0.00158	CcSEcCtD
Risedronate—Rash—Lovastatin—atherosclerosis	0.000371	0.00158	CcSEcCtD
Risedronate—Dermatitis—Lovastatin—atherosclerosis	0.000371	0.00158	CcSEcCtD
Risedronate—Headache—Lovastatin—atherosclerosis	0.000369	0.00157	CcSEcCtD
Risedronate—Vomiting—Ezetimibe—atherosclerosis	0.000367	0.00156	CcSEcCtD
Risedronate—Hypersensitivity—Pravastatin—atherosclerosis	0.000367	0.00156	CcSEcCtD
Risedronate—Dizziness—Simvastatin—atherosclerosis	0.000364	0.00155	CcSEcCtD
Risedronate—Rash—Ezetimibe—atherosclerosis	0.000364	0.00155	CcSEcCtD
Risedronate—Dermatitis—Ezetimibe—atherosclerosis	0.000364	0.00155	CcSEcCtD
Risedronate—Asthenia—Niacin—atherosclerosis	0.000363	0.00154	CcSEcCtD
Risedronate—Headache—Ezetimibe—atherosclerosis	0.000362	0.00154	CcSEcCtD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—ESR1—atherosclerosis	0.000362	0.00286	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	0.000361	0.00286	CbGpPWpGaD
Risedronate—Pruritus—Niacin—atherosclerosis	0.000358	0.00152	CcSEcCtD
Risedronate—Asthenia—Pravastatin—atherosclerosis	0.000357	0.00152	CcSEcCtD
Risedronate—PTGS2—Overview of nanoparticle effects—TNF—atherosclerosis	0.000356	0.00282	CbGpPWpGaD
Risedronate—Pruritus—Pravastatin—atherosclerosis	0.000352	0.0015	CcSEcCtD
Risedronate—Vomiting—Simvastatin—atherosclerosis	0.00035	0.00149	CcSEcCtD
Risedronate—Nausea—Lovastatin—atherosclerosis	0.00035	0.00149	CcSEcCtD
Risedronate—Rash—Simvastatin—atherosclerosis	0.000347	0.00147	CcSEcCtD
Risedronate—Dermatitis—Simvastatin—atherosclerosis	0.000347	0.00147	CcSEcCtD
Risedronate—Diarrhoea—Niacin—atherosclerosis	0.000346	0.00147	CcSEcCtD
Risedronate—Headache—Simvastatin—atherosclerosis	0.000345	0.00147	CcSEcCtD
Risedronate—Nausea—Ezetimibe—atherosclerosis	0.000343	0.00146	CcSEcCtD
Risedronate—PTGS2—Selenium Micronutrient Network—ABCA1—atherosclerosis	0.000343	0.00271	CbGpPWpGaD
Risedronate—Diarrhoea—Pravastatin—atherosclerosis	0.000341	0.00145	CcSEcCtD
Risedronate—Dizziness—Niacin—atherosclerosis	0.000335	0.00142	CcSEcCtD
Risedronate—Dizziness—Pravastatin—atherosclerosis	0.000329	0.0014	CcSEcCtD
Risedronate—Nausea—Simvastatin—atherosclerosis	0.000327	0.00139	CcSEcCtD
Risedronate—Vomiting—Niacin—atherosclerosis	0.000322	0.00137	CcSEcCtD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	0.000322	0.00255	CbGpPWpGaD
Risedronate—Rash—Niacin—atherosclerosis	0.000319	0.00135	CcSEcCtD
Risedronate—PTGS2—Selenium Micronutrient Network—PLG—atherosclerosis	0.000319	0.00252	CbGpPWpGaD
Risedronate—Dermatitis—Niacin—atherosclerosis	0.000319	0.00135	CcSEcCtD
Risedronate—Headache—Niacin—atherosclerosis	0.000317	0.00135	CcSEcCtD
Risedronate—Vomiting—Pravastatin—atherosclerosis	0.000317	0.00134	CcSEcCtD
Risedronate—Rash—Pravastatin—atherosclerosis	0.000314	0.00133	CcSEcCtD
Risedronate—Dermatitis—Pravastatin—atherosclerosis	0.000314	0.00133	CcSEcCtD
Risedronate—Headache—Pravastatin—atherosclerosis	0.000312	0.00132	CcSEcCtD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—atherosclerosis	0.000309	0.00244	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ABCG1—atherosclerosis	0.000306	0.00242	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—SOD1—atherosclerosis	0.000306	0.00242	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—CCR2—atherosclerosis	0.000304	0.00241	CbGpPWpGaD
Risedronate—Nausea—Niacin—atherosclerosis	0.000301	0.00128	CcSEcCtD
Risedronate—Nausea—Pravastatin—atherosclerosis	0.000296	0.00126	CcSEcCtD
Risedronate—FDPS—Metabolism—LCAT—atherosclerosis	0.000288	0.00228	CbGpPWpGaD
Risedronate—FDPS—Metabolism—FABP4—atherosclerosis	0.000288	0.00228	CbGpPWpGaD
Risedronate—PTGS2—Overview of nanoparticle effects—IL6—atherosclerosis	0.000287	0.00227	CbGpPWpGaD
Risedronate—PTGS2—C-MYB transcription factor network—GSTM1—atherosclerosis	0.000284	0.00225	CbGpPWpGaD
Risedronate—FDPS—Metabolism—APOA4—atherosclerosis	0.000282	0.00223	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—APOB—atherosclerosis	0.000282	0.00223	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CYP7A1—atherosclerosis	0.000277	0.0022	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—SOD2—atherosclerosis	0.000275	0.00218	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	0.000264	0.00209	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—GPX1—atherosclerosis	0.000262	0.00208	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CYP27A1—atherosclerosis	0.000256	0.00203	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—LDLRAP1—atherosclerosis	0.000255	0.00202	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—atherosclerosis	0.000253	0.00201	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	0.000252	0.002	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—atherosclerosis	0.000252	0.002	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	0.000246	0.00195	CbGpPWpGaD
Risedronate—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—atherosclerosis	0.000244	0.00194	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PLA2G2A—atherosclerosis	0.000243	0.00192	CbGpPWpGaD
Risedronate—FDPS—Metabolism—APOA2—atherosclerosis	0.000243	0.00192	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ALOX15—atherosclerosis	0.000243	0.00192	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ALOX5AP—atherosclerosis	0.000243	0.00192	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—MTHFR—atherosclerosis	0.000242	0.00192	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ABCG5—atherosclerosis	0.00024	0.0019	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PLTP—atherosclerosis	0.00024	0.0019	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	0.00024	0.0019	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—atherosclerosis	0.000236	0.00187	CbGpPWpGaD
Risedronate—FDPS—Metabolism—LPA—atherosclerosis	0.000232	0.00184	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—CRP—atherosclerosis	0.00023	0.00182	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—atherosclerosis	0.000225	0.00178	CbGpPWpGaD
Risedronate—FDPS—Metabolism—BGN—atherosclerosis	0.000225	0.00178	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—APOA1—atherosclerosis	0.000223	0.00176	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	0.000223	0.00176	CbGpPWpGaD
Risedronate—FDPS—Metabolism—APOA5—atherosclerosis	0.000222	0.00176	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	0.000216	0.00171	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PLA2G1B—atherosclerosis	0.000214	0.00169	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—F2—atherosclerosis	0.000213	0.00168	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—ICAM1—atherosclerosis	0.000212	0.00168	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	0.000212	0.00167	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	0.00021	0.00166	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	0.000209	0.00166	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—LTA4H—atherosclerosis	0.000208	0.00165	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ABCG8—atherosclerosis	0.000208	0.00165	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ALOX5—atherosclerosis	0.000207	0.00164	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—atherosclerosis	0.000205	0.00162	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—INS—atherosclerosis	0.000193	0.00153	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—ESR2—atherosclerosis	0.000191	0.00151	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	0.000191	0.00151	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—CCL2—atherosclerosis	0.00019	0.0015	CbGpPWpGaD
Risedronate—FDPS—Metabolism—NAMPT—atherosclerosis	0.000185	0.00147	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	0.000184	0.00146	CbGpPWpGaD
Risedronate—FDPS—Metabolism—LIPC—atherosclerosis	0.000184	0.00146	CbGpPWpGaD
Risedronate—FDPS—Metabolism—APOC3—atherosclerosis	0.000183	0.00145	CbGpPWpGaD
Risedronate—FDPS—Metabolism—LDLR—atherosclerosis	0.000182	0.00144	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—LEP—atherosclerosis	0.000178	0.00141	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CETP—atherosclerosis	0.000178	0.00141	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—SERPINE1—atherosclerosis	0.000177	0.0014	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—ALB—atherosclerosis	0.000177	0.0014	CbGpPWpGaD
Risedronate—PTGS2—Aryl Hydrocarbon Receptor—TNF—atherosclerosis	0.000175	0.00139	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—TLR4—atherosclerosis	0.000175	0.00138	CbGpPWpGaD
Risedronate—FDPS—Metabolism—SCARB1—atherosclerosis	0.00017	0.00135	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—ICAM1—atherosclerosis	0.000168	0.00133	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—NOS2—atherosclerosis	0.000166	0.00132	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	0.000166	0.00131	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ABCG1—atherosclerosis	0.000165	0.0013	CbGpPWpGaD
Risedronate—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—atherosclerosis	0.000164	0.0013	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—IFNG—atherosclerosis	0.000161	0.00128	CbGpPWpGaD
Risedronate—FDPS—Metabolism—HMGCR—atherosclerosis	0.000161	0.00127	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—LCAT—atherosclerosis	0.000155	0.00122	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—FABP4—atherosclerosis	0.000155	0.00122	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—SIRT1—atherosclerosis	0.000154	0.00122	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—APOA4—atherosclerosis	0.000152	0.0012	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—CCL2—atherosclerosis	0.00015	0.00119	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CYP7A1—atherosclerosis	0.000149	0.00118	CbGpPWpGaD
Risedronate—FDPS—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	0.000145	0.00115	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—IL1B—atherosclerosis	0.000144	0.00114	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ABCA1—atherosclerosis	0.000143	0.00113	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	0.000138	0.00109	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—atherosclerosis	0.000137	0.00109	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—NFKB1—atherosclerosis	0.000134	0.00106	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	0.000131	0.00103	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	0.000131	0.00103	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	0.000131	0.00103	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	0.000131	0.00103	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	0.000129	0.00102	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IFNG—atherosclerosis	0.000127	0.00101	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	0.000125	0.000987	CbGpPWpGaD
Risedronate—FDPS—Metabolism—HMOX1—atherosclerosis	0.000123	0.000973	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	0.00012	0.000946	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—CXCL8—atherosclerosis	0.000119	0.000938	CbGpPWpGaD
Risedronate—FDPS—Metabolism—APOB—atherosclerosis	0.000118	0.000932	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—atherosclerosis	0.000116	0.000917	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	0.000115	0.000911	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GSTM1—atherosclerosis	0.000114	0.000906	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL1B—atherosclerosis	0.000114	0.0009	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—LDLRAP1—atherosclerosis	0.000114	0.0009	CbGpPWpGaD
Risedronate—FDPS—Metabolism—LPL—atherosclerosis	0.000112	0.00089	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	0.000111	0.00088	CbGpPWpGaD
Risedronate—FDPS—Metabolism—GPX1—atherosclerosis	0.00011	0.000868	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—MMP9—atherosclerosis	0.000107	0.000849	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PLTP—atherosclerosis	0.000107	0.000846	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CD36—atherosclerosis	0.000107	0.000845	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—TNF—atherosclerosis	0.000104	0.000826	CbGpPWpGaD
Risedronate—FDPS—Metabolism—MTHFR—atherosclerosis	0.000101	0.000801	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—atherosclerosis	0.0001	0.000794	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PPARA—atherosclerosis	9.93e-05	0.000786	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	9.9e-05	0.000784	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	9.84e-05	0.000779	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	9.78e-05	0.000775	CbGpPWpGaD
Risedronate—FDPS—Metabolism—AGT—atherosclerosis	9.61e-05	0.000761	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	9.56e-05	0.000757	CbGpPWpGaD
Risedronate—FDPS—Metabolism—APOE—atherosclerosis	9.42e-05	0.000746	CbGpPWpGaD
Risedronate—FDPS—Metabolism—CAV1—atherosclerosis	9.33e-05	0.000739	CbGpPWpGaD
Risedronate—FDPS—Metabolism—APOA1—atherosclerosis	9.31e-05	0.000737	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—LTA4H—atherosclerosis	9.27e-05	0.000734	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ABCG8—atherosclerosis	9.27e-05	0.000734	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	9.15e-05	0.000724	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—MAPK3—atherosclerosis	9.11e-05	0.000721	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—TGFB1—atherosclerosis	8.84e-05	0.000699	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	8.64e-05	0.000684	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PIK3CG—atherosclerosis	8.5e-05	0.000673	CbGpPWpGaD
Risedronate—PTGS2—Selenium Micronutrient Network—IL6—atherosclerosis	8.42e-05	0.000666	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—TNF—atherosclerosis	8.25e-05	0.000653	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PPARG—atherosclerosis	8.21e-05	0.00065	CbGpPWpGaD
Risedronate—PTGS2—Disease—APOA4—atherosclerosis	8.07e-05	0.000639	CbGpPWpGaD
Risedronate—FDPS—Metabolism—INS—atherosclerosis	8.05e-05	0.000637	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	7.7e-05	0.00061	CbGpPWpGaD
Risedronate—FDPS—Metabolism—ALB—atherosclerosis	7.38e-05	0.000584	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ABCG1—atherosclerosis	7.33e-05	0.00058	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—atherosclerosis	7.22e-05	0.000571	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—atherosclerosis	7.09e-05	0.000561	CbGpPWpGaD
Risedronate—FDPS—Metabolism—NOS3—atherosclerosis	7.06e-05	0.000559	CbGpPWpGaD
Risedronate—PTGS2—Disease—APOA2—atherosclerosis	6.95e-05	0.00055	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—FABP4—atherosclerosis	6.89e-05	0.000545	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—LCAT—atherosclerosis	6.89e-05	0.000545	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—APOA4—atherosclerosis	6.76e-05	0.000535	CbGpPWpGaD
Risedronate—PTGS2—Spinal Cord Injury—IL6—atherosclerosis	6.66e-05	0.000527	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP7A1—atherosclerosis	6.64e-05	0.000526	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—atherosclerosis	6.55e-05	0.000518	CbGpPWpGaD
Risedronate—FDPS—Metabolism—PTGS2—atherosclerosis	6.45e-05	0.000511	CbGpPWpGaD
Risedronate—PTGS2—Disease—BGN—atherosclerosis	6.42e-05	0.000508	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	6.33e-05	0.000501	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—atherosclerosis	6.19e-05	0.00049	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CYP27A1—atherosclerosis	6.14e-05	0.000486	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	6.04e-05	0.000479	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—atherosclerosis	6.01e-05	0.000476	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	5.9e-05	0.000467	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PLA2G2A—atherosclerosis	5.82e-05	0.000461	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—APOA2—atherosclerosis	5.82e-05	0.000461	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ALOX15—atherosclerosis	5.82e-05	0.000461	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ALOX5AP—atherosclerosis	5.82e-05	0.000461	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ABCG5—atherosclerosis	5.75e-05	0.000455	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	5.74e-05	0.000455	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—atherosclerosis	5.61e-05	0.000444	CbGpPWpGaD
Risedronate—PTGS2—Disease—CST3—atherosclerosis	5.6e-05	0.000443	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—LPA—atherosclerosis	5.55e-05	0.00044	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—BGN—atherosclerosis	5.38e-05	0.000426	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	5.34e-05	0.000423	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—APOA5—atherosclerosis	5.32e-05	0.000421	CbGpPWpGaD
Risedronate—PTGS2—Disease—NAMPT—atherosclerosis	5.3e-05	0.00042	CbGpPWpGaD
Risedronate—PTGS2—Disease—APOC3—atherosclerosis	5.23e-05	0.000414	CbGpPWpGaD
Risedronate—PTGS2—Disease—LDLR—atherosclerosis	5.2e-05	0.000412	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	5.17e-05	0.000409	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PLA2G1B—atherosclerosis	5.12e-05	0.000406	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	5.07e-05	0.000401	CbGpPWpGaD
Risedronate—PTGS2—Disease—HSPA1B—atherosclerosis	5.02e-05	0.000398	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	5.02e-05	0.000397	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	5.01e-05	0.000396	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ALOX5—atherosclerosis	4.95e-05	0.000392	CbGpPWpGaD
Risedronate—PTGS2—Disease—NCF1—atherosclerosis	4.87e-05	0.000385	CbGpPWpGaD
Risedronate—PTGS2—Disease—CYBA—atherosclerosis	4.58e-05	0.000362	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.57e-05	0.000362	CbGpPWpGaD
Risedronate—PTGS2—Disease—PARP1—atherosclerosis	4.48e-05	0.000355	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NAMPT—atherosclerosis	4.44e-05	0.000351	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	4.41e-05	0.000349	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—LIPC—atherosclerosis	4.41e-05	0.000349	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—APOC3—atherosclerosis	4.38e-05	0.000347	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—LDLR—atherosclerosis	4.36e-05	0.000345	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CETP—atherosclerosis	4.26e-05	0.000337	CbGpPWpGaD
Risedronate—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—atherosclerosis	4.18e-05	0.000331	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—SCARB1—atherosclerosis	4.08e-05	0.000323	CbGpPWpGaD
Risedronate—PTGS2—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.97e-05	0.000314	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HMGCR—atherosclerosis	3.85e-05	0.000305	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ABCA1—atherosclerosis	3.43e-05	0.000272	CbGpPWpGaD
Risedronate—PTGS2—Disease—APOB—atherosclerosis	3.37e-05	0.000266	CbGpPWpGaD
Risedronate—FDPS—Metabolism—AKT1—atherosclerosis	3.24e-05	0.000257	CbGpPWpGaD
Risedronate—PTGS2—Disease—LPL—atherosclerosis	3.21e-05	0.000254	CbGpPWpGaD
Risedronate—PTGS2—Disease—PRKCG—atherosclerosis	3.13e-05	0.000247	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—HMOX1—atherosclerosis	2.94e-05	0.000233	CbGpPWpGaD
Risedronate—PTGS2—Disease—MTHFR—atherosclerosis	2.89e-05	0.000229	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—APOB—atherosclerosis	2.82e-05	0.000223	CbGpPWpGaD
Risedronate—PTGS2—Disease—PDGFB—atherosclerosis	2.82e-05	0.000223	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GSTM1—atherosclerosis	2.74e-05	0.000217	CbGpPWpGaD
Risedronate—PTGS2—Disease—APOE—atherosclerosis	2.69e-05	0.000213	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—LPL—atherosclerosis	2.69e-05	0.000213	CbGpPWpGaD
Risedronate—PTGS2—Disease—CAV1—atherosclerosis	2.67e-05	0.000211	CbGpPWpGaD
Risedronate—PTGS2—Disease—APOA1—atherosclerosis	2.66e-05	0.000211	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—GPX1—atherosclerosis	2.63e-05	0.000208	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CD36—atherosclerosis	2.56e-05	0.000202	CbGpPWpGaD
Risedronate—PTGS2—Disease—NOS2—atherosclerosis	2.51e-05	0.000199	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—MTHFR—atherosclerosis	2.42e-05	0.000192	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PPARA—atherosclerosis	2.38e-05	0.000188	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—AGT—atherosclerosis	2.3e-05	0.000182	CbGpPWpGaD
Risedronate—PTGS2—Disease—INS—atherosclerosis	2.3e-05	0.000182	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—APOE—atherosclerosis	2.26e-05	0.000179	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—CAV1—atherosclerosis	2.24e-05	0.000177	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—APOA1—atherosclerosis	2.23e-05	0.000177	CbGpPWpGaD
Risedronate—PTGS2—Disease—SERPINE1—atherosclerosis	2.11e-05	0.000167	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PIK3CG—atherosclerosis	2.04e-05	0.000161	CbGpPWpGaD
Risedronate—PTGS2—Disease—NOS3—atherosclerosis	2.02e-05	0.00016	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—PPARG—atherosclerosis	1.97e-05	0.000156	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—INS—atherosclerosis	1.93e-05	0.000153	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—ALB—atherosclerosis	1.77e-05	0.00014	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—NOS3—atherosclerosis	1.69e-05	0.000134	CbGpPWpGaD
Risedronate—PTGS2—Disease—STAT3—atherosclerosis	1.44e-05	0.000114	CbGpPWpGaD
Risedronate—PTGS2—Disease—MAPK3—atherosclerosis	1.38e-05	0.000109	CbGpPWpGaD
Risedronate—PTGS2—Disease—TGFB1—atherosclerosis	1.33e-05	0.000106	CbGpPWpGaD
Risedronate—PTGS2—Disease—IL6—atherosclerosis	1.01e-05	7.96e-05	CbGpPWpGaD
Risedronate—PTGS2—Disease—AKT1—atherosclerosis	9.28e-06	7.35e-05	CbGpPWpGaD
Risedronate—PTGS2—Metabolism—AKT1—atherosclerosis	7.77e-06	6.15e-05	CbGpPWpGaD
